APA (7th ed.) Citation

SA, M., D, J., KE, T. P., PA, C., ME, F., EW, C., . . . SZ, P. (2011). A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: Feasibility, interrater reliability, and minimum detectable change. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 17(11), 1619. https://doi.org/10.1016/j.bbmt.2011.04.002

Chicago Style (17th ed.) Citation

SA, Mitchell, et al. "A Multicenter Pilot Evaluation of the National Institutes of Health Chronic Graft-versus-host Disease (cGVHD) Therapeutic Response Measures: Feasibility, Interrater Reliability, and Minimum Detectable Change." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 17, no. 11 (2011): 1619. https://doi.org/10.1016/j.bbmt.2011.04.002.

MLA (9th ed.) Citation

SA, Mitchell, et al. "A Multicenter Pilot Evaluation of the National Institutes of Health Chronic Graft-versus-host Disease (cGVHD) Therapeutic Response Measures: Feasibility, Interrater Reliability, and Minimum Detectable Change." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, vol. 17, no. 11, 2011, p. 1619, https://doi.org/10.1016/j.bbmt.2011.04.002.